Commercial 360° investment intelligence

See the business behind the pitch deck.

SCALEUP.report is an ultra-fast, senior-assisted Business MRI built primarily for investors evaluating, acquiring, or supporting growth companies. For founders and CEOs, it also provides an objective priority check, exposes scalability gaps, cross-checks current plans, and strengthens preparation for investor meetings and due diligence.

Explore your case ↗

SCALEUP.report

Confidential

Investment Decision Brief

Illustrative company · Growth stage

Proceed with conditions

Commercial score74/100

Evidence confidence84%

Market

Revenue engine

Operations

Leadership

Governance

120+

Companies assessed so far and counting

Business dimensions

300+

Scalability levers checked

1report

Investor decision layer + founder readiness baseline

One assessment, three value moments

Get Value on Day One

A relatively small, fixed-scope assessment can protect a much larger capital decision, help a founder enter the process better prepared, and continue creating value after the transaction closes.

ProceedVerifyAttach conditionsPauseWalk away

Investment decision support

Test the investability of the operating system.

Separate what is proven from what is merely asserted, expose the failure modes that matter, and make the remaining uncertainty actionable.

Validate the investment thesis against commercial reality
Prioritise confirmatory diligence and management questions
Translate uncertainty into price, conditions, milestones, or conviction
Reject weak opportunities faster without exhausting the deal team

Investor use cases

Built around the capital decision not around a consultant’s process.

The assessment depth adapts to the materiality of the opportunity, access to evidence, and the specific decision the investor, acquirer, board, or founder needs to make.

Individual capital

Angels & syndicates

Rapidly distinguish a compelling founder narrative from an investable operating model-and identify the few questions that should determine conviction.

Outcome: sharper screening and fewer avoidable blind spots.

Institutional venture

VC & CVC teams

Create a consistent commercial and organisational view for partner discussion, Investment Committee preparation, follow-on decisions, and portfolio support.

Outcome: IC-ready synthesis with visible evidence confidence.

Long-term capital

Family offices

Strengthen decision quality when internal operating resources are limited or when an opportunity sits outside the team’s deepest sector pattern recognition.

Outcome: proportionate diligence without building a large process.

Control & growth

Growth equity & PE

Connect commercial performance, operating scalability, management capacity, governance, and the first value-creation sequence before the deal closes.

Outcome: a thesis-linked Day‑0 operating baseline.

Acquisition

Search funds & M&A

Evaluate owner dependency, customer quality, revenue durability, leadership transition risk, and whether the business can operate beyond its current configuration.

Outcome: clearer acquisition risk and transition priorities.

Portfolio value

Boards & founders

Use the same evidence base to align the board and leadership team on what matters now, what must wait, and which indicators will show whether the company is becoming more scalable.

Outcome: shared priorities, owners, milestones, and review cadence.

Founder & CEO value

Pressure test the company before investors do.

Founders and CEOs can commission SCALEUP.report before fundraising, a transaction, or a major scaling phase. It objectively tests priorities and current plans, reveals scalability gaps, and shows how investors are likely to interpret the business.

Before outreach

Build a more credible investment story

Connect market opportunity, traction, scalability, leadership capacity, and capital needs into one evidence-backed story.

Founder benefit: stronger confidence without overclaiming.

Investor meetings

Rehearse the hard questions

Identify weak evidence, inconsistent metrics, likely objections, and the questions most likely to surface in investor meetings.

Founder benefit: fewer surprises and sharper answers.

Due diligence

Enter the data room prepared

Map missing evidence, fragile assumptions, ownership gaps, and operational weaknesses before diligence begins.

Business benefit: a cleaner, faster diligence process.

Negotiation

Understand the company's risk narrative

See which issues may influence valuation, terms, milestones, governance, or the perceived need for investor intervention.

Founder benefit: negotiate from a more informed position.

Internal alignment

Align the leadership team

Create one objective view of priorities, plan quality, execution dependencies, and the improvements that matter most.

Business benefit: one roadmap, not competing narratives.

Value creation

Improve the business-not only the presentation

Convert findings into a focused 90-day plan with owners, evidence milestones, and review cadence.

Business benefit: readiness becomes measurable progress.

Founder-initiated report

Independent preparation-not a guaranteed investor endorsement.

The report helps leadership validate priorities, challenge current plans, expose scaling constraints, and address weaknesses earlier. Credibility still depends on independent judgment, evidence discipline, and transparent limitations.

Objective priority and current-plan cross-check
Scalability and execution-gap map
Investor meeting and due-diligence rehearsal
Priority fixes before the next investor interaction

Three report levels

Match the right depth level to your needs.

Every level uses the same independent framework. Reports may be commissioned by an investor, acquirer, board, founder, or CEO; the difference is depth of evidence, breadth of stakeholder input, and whether leadership dynamics are included.

12-dimension methodology

Multiple business areas in one coherent view.

Each conclusion is paired with evidence confidence, benchmark logic, risk severity, upside potential, and a recommended time horizon-because a naked score creates false precision.

Assessment workflow

Four steps to the scaling clarity

The exact scope adapts to access, urgency, commissioning party, and report level. The operating principle stays constant: maximum signal, minimum theatre.

Frame the decision

Define the investment question or readiness objective, process stage, known concerns, access constraints, and required output.

Collect evidence

Review available metrics, documents, data-room materials, and targeted management inputs.

Challenge & benchmark

A senior investment and scaleup operator tests the evidence across the 12 dimensions and peer logic.

Deliver the brief

Receive an IC-ready or investor-readiness report, live readout, priority questions, evidence gaps, and-where relevant-a 90-day action plan.

Illustrative output

An Action-ready synthesis not a pile of consultant slides.

The report connects findings to decisions. It makes evidence quality, trade-offs, dependencies, and the post-close agenda visible in one structured view.

Recommended path

Proceed to confirmatory diligence-with three conditions.

The company shows real category pull and strong customer advocacy. The principal risks are enterprise concentration, founder-dependent sales, and weak implementation capacity.

01 Validate top-account renewal exposure

02 Hire an implementation leader

03 Formalise enterprise pipeline governance

Why the thesis can work

High-value workflowClear customer ROI and strong daily product relevance.

Account expansionMeaningful expansion inside mature, well-implemented customers.

Defensible data advantageDomain data compounds product value and customer switching cost.

Finding	Severity	Evidence confidence	Investment implication
Revenue concentration Two enterprise accounts influence reported retention quality.	High	86%	Rebuild account-level cohorts and validate renewal exposure.
Founder-dependent sales Founder remains involved in most strategic late-stage deals.	High	91%	Treat repeatability as a condition, not a future aspiration.
International channel economics Partner activation and contribution margin are not yet evidenced.	Medium	43%	Pause expansion until economics and ownership are validated.
Product roadmap capacity Customer commitments may crowd out platform work.	Medium	61%	Confirm delivery capacity and roadmap trade-offs.

Days 0-30

Stabilise the baseline

Rebuild account-level retention cohorts
Define sales qualification and forecast rules
Recruit implementation leadership

Days 31-60

Reduce dependencies

Separate founder sponsorship from sales ownership
Install delivery capacity planning
Create board-level commercial dashboard

Days 61-90

Test value creation

Launch pricing and packaging experiment
Activate mature-account expansion play
Re-assess thesis-linked dimensions

Observed strengths

High strategic pattern recognition
Strong customer credibility
Complementarity across product and commercial domains

Scaling dependencies

Founder remains the default escalation path
Conflict is delayed until decisions become urgent
Decision rights are not explicit when founders disagree

Practical actions

Define founder-only versus delegated decisions
Introduce a conflict and escalation protocol
Shift the founder to strategic sponsorship, not process ownership

Illustrative only. A real module requires informed consent, validated instruments, qualified interpretation, and an agreed protocol for sensitive information. It is not a clinical diagnosis or a standalone investment verdict.

Proof from both sides of the table

References

Make scaling with a clearer view.

Investors can scope a decision assessment. Founders and CEOs can validate priorities, plans, scalability, and investment readiness before outreach or due diligence.